97 related articles for article (PubMed ID: 7648384)
1. Pharmacology of long-acting beta-agonists.
Johnson M
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):177-9. PubMed ID: 7648384
[TBL] [Abstract][Full Text] [Related]
2. Long-acting beta 2-adrenoceptor agonists: a new perspective in the treatment of asthma.
Löfdahl CG; Chung KF
Eur Respir J; 1991 Feb; 4(2):218-26. PubMed ID: 1675178
[TBL] [Abstract][Full Text] [Related]
3. Long-acting beta 2-agonists. Role in primary care asthma treatment.
D'Urzo AD
Can Fam Physician; 1997 Oct; 43():1773-7. PubMed ID: 9356758
[TBL] [Abstract][Full Text] [Related]
4. Different bronchodilating effect of salmeterol and formoterol in an adult asthmatic.
Ulrik CS; Kok-Jensen A
Eur Respir J; 1994 May; 7(5):1003-5. PubMed ID: 7914175
[TBL] [Abstract][Full Text] [Related]
5. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma.
Campbell LM
Int J Clin Pract; 2002 Dec; 56(10):783-90. PubMed ID: 12510953
[TBL] [Abstract][Full Text] [Related]
6. [Long-acting beta-2-agonists in the treatment of asthma].
Rochat T
Schweiz Med Wochenschr; 1994 Oct; 124(39):1714-9. PubMed ID: 7939538
[TBL] [Abstract][Full Text] [Related]
7. Long-acting inhaled beta 2-agonists in the management of asthma: recent advances and current recommendations.
Redington AE; Rees PJ
Int J Clin Pract; 1998 Oct; 52(7):482-6. PubMed ID: 10622090
[TBL] [Abstract][Full Text] [Related]
8. Comparison of duration of agonist action at beta 1- and beta 2- adrenoceptors in C6 glioma cells: evidence that the long duration of action of salmeterol is specific to the beta 2-adrenoceptor.
McCrea KE; Hill SJ
Mol Pharmacol; 1996 May; 49(5):927-37. PubMed ID: 8622643
[TBL] [Abstract][Full Text] [Related]
9. State of the art in beta2-agonist therapy: a safety review of long-acting agents.
Rabe KF
Int J Clin Pract; 2003 Oct; 57(8):689-97. PubMed ID: 14627180
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of abediterol, a novel inhaled β(2)-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models.
Aparici M; Gómez-Angelats M; Vilella D; Otal R; Carcasona C; Viñals M; Ramos I; Gavaldà A; De Alba J; Gras J; Cortijo J; Morcillo E; Puig C; Ryder H; Beleta J; Miralpeix M
J Pharmacol Exp Ther; 2012 Aug; 342(2):497-509. PubMed ID: 22588259
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma.
Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D
Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143
[TBL] [Abstract][Full Text] [Related]
12. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
Pearlman DS
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):180-4. PubMed ID: 7648385
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy with formoterol in the absence of a response to salmeterol: a review.
Kottakis J; Wood R; Le Gros V; Della Cioppa G
Int J Clin Pract; 2001 Sep; 55(7):476-9. PubMed ID: 11594259
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic aspects of salmeterol therapy.
Buchwald A; Hochhaus G
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):652-60. PubMed ID: 9877002
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
Sin DD; Man SF
Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
[TBL] [Abstract][Full Text] [Related]
17. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
18. Beta 2-agonists as anti-inflammatory therapies in the lung.
Johnson M
Agents Actions Suppl; 1993; 41():27-45. PubMed ID: 8100394
[TBL] [Abstract][Full Text] [Related]
19. Salmeterol: a long-acting beta 2-agonist.
D'Alonzo GE; Tolep K
J Am Osteopath Assoc; 1998 Apr; 98(4):216-8, 221-31. PubMed ID: 9594486
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of drug-receptor interactions of long-acting beta2 sympathomimetics in isolated receptor membranes: evidence against prolonged effects of salmeterol and formoterol on receptor-coupled adenylyl cyclase.
Teschemacher A; Lemoine H
J Pharmacol Exp Ther; 1999 Mar; 288(3):1084-92. PubMed ID: 10027845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]